Beclabuvir
Beclabuvir
Beclabuvir (pronounced as bek-la-BYOO-vir) is an antiviral drug that was under development for the treatment of hepatitis C. It is a non-nucleoside NS5B inhibitor, which means it works by preventing the virus from replicating in the body.
Etymology
The name "Beclabuvir" is derived from the systematic chemical name of the drug, which is (S)-N-(4-((1-((1,1'-biphenyl)-4-yl)-2,2,2-trifluoroethyl)amino)-3-fluoropyridin-2-yl)-2,2-difluoroacetamide. The "-buvir" suffix is common in antiviral drugs, particularly those that inhibit the NS5B protein.
Related Terms
- Antiviral drug: A type of medication used specifically for treating viral infections.
- Hepatitis C: A viral infection that causes liver inflammation, sometimes leading to serious liver damage.
- NS5B: A viral protein that is essential for the replication of the hepatitis C virus.
See Also
External links
- Medical encyclopedia article on Beclabuvir
- Wikipedia's article - Beclabuvir
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski